Personalized Medicine: Pharmacogenomics and Drug Development
Personalized medicine aims is to supply the proper drug to the proper patient within the right dose. Pharmacogenomics (PGx) is to recognize genetic variants that may influence drug efficacy and toxicity. All things considered, the fields cover a wide area, including basic drug discovery researches,...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2017-03-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | https://acta.tums.ac.ir/index.php/acta/article/view/6211 |
_version_ | 1818759479106207744 |
---|---|
author | Somayeh Mirsadeghi Bagher Larijani |
author_facet | Somayeh Mirsadeghi Bagher Larijani |
author_sort | Somayeh Mirsadeghi |
collection | DOAJ |
description | Personalized medicine aims is to supply the proper drug to the proper patient within the right dose. Pharmacogenomics (PGx) is to recognize genetic variants that may influence drug efficacy and toxicity. All things considered, the fields cover a wide area, including basic drug discovery researches, the genetic origin of pharmacokinetics and pharmacodynamics, novel drug improvement, patient genetic assessment and clinical patient administration. At last, the objective of Pharmacogenomics is to anticipate a patient’s genetic response to a particular drug as a way of presenting the best possible medical treatment. By predicting the drug response of an individual, it will be possible to increase the success of therapies and decrease the incidence of adverse side effect. |
first_indexed | 2024-12-18T06:43:22Z |
format | Article |
id | doaj.art-201fab6acfa7450e996cfb2eecaeae43 |
institution | Directory Open Access Journal |
issn | 0044-6025 1735-9694 |
language | English |
last_indexed | 2024-12-18T06:43:22Z |
publishDate | 2017-03-01 |
publisher | Tehran University of Medical Sciences |
record_format | Article |
series | Acta Medica Iranica |
spelling | doaj.art-201fab6acfa7450e996cfb2eecaeae432022-12-21T21:17:34ZengTehran University of Medical SciencesActa Medica Iranica0044-60251735-96942017-03-015535131Personalized Medicine: Pharmacogenomics and Drug DevelopmentSomayeh Mirsadeghi0Bagher Larijani1Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.Personalized medicine aims is to supply the proper drug to the proper patient within the right dose. Pharmacogenomics (PGx) is to recognize genetic variants that may influence drug efficacy and toxicity. All things considered, the fields cover a wide area, including basic drug discovery researches, the genetic origin of pharmacokinetics and pharmacodynamics, novel drug improvement, patient genetic assessment and clinical patient administration. At last, the objective of Pharmacogenomics is to anticipate a patient’s genetic response to a particular drug as a way of presenting the best possible medical treatment. By predicting the drug response of an individual, it will be possible to increase the success of therapies and decrease the incidence of adverse side effect.https://acta.tums.ac.ir/index.php/acta/article/view/6211Personalized medicinePharmacogeneticsDrug discoveryDrug safety |
spellingShingle | Somayeh Mirsadeghi Bagher Larijani Personalized Medicine: Pharmacogenomics and Drug Development Acta Medica Iranica Personalized medicine Pharmacogenetics Drug discovery Drug safety |
title | Personalized Medicine: Pharmacogenomics and Drug Development |
title_full | Personalized Medicine: Pharmacogenomics and Drug Development |
title_fullStr | Personalized Medicine: Pharmacogenomics and Drug Development |
title_full_unstemmed | Personalized Medicine: Pharmacogenomics and Drug Development |
title_short | Personalized Medicine: Pharmacogenomics and Drug Development |
title_sort | personalized medicine pharmacogenomics and drug development |
topic | Personalized medicine Pharmacogenetics Drug discovery Drug safety |
url | https://acta.tums.ac.ir/index.php/acta/article/view/6211 |
work_keys_str_mv | AT somayehmirsadeghi personalizedmedicinepharmacogenomicsanddrugdevelopment AT bagherlarijani personalizedmedicinepharmacogenomicsanddrugdevelopment |